Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
ZYNE Zynerba Pharmaceuticals, Inc. weekly Stock Chart
ZYNE [NASD]
Zynerba Pharmaceuticals, Inc.
Healthcare | Drug Manufacturers - Specialty & Generic | USA
statements
Index- P/E- EPS (ttm)-1.58 Insider Own12.32% Shs Outstand23.40M Perf Week-9.05%
Market Cap143.96M Forward P/E- EPS next Y-1.60 Insider Trans0.00% Shs Float22.05M Perf Month52.16%
Income-36.10M PEG- EPS next Q-0.45 Inst Own38.30% Short Float26.11% Perf Quarter34.69%
Sales- P/S- EPS this Y42.60% Inst Trans-13.69% Short Ratio7.18 Perf Half Y-11.06%
Book/sh2.83 P/B1.99 EPS next Y13.70% ROA-40.80% Target Price- Perf Year-46.18%
Cash/sh2.37 P/C2.38 EPS next 5Y- ROE-46.30% 52W Range2.55 - 15.70 Perf YTD-6.79%
Dividend- P/FCF- EPS past 5Y-17.80% ROI- 52W High-64.97% Beta3.13
Dividend %- Quick Ratio7.30 Sales past 5Y- Gross Margin- 52W Low115.64% ATR0.51
Employees28 Current Ratio7.30 Sales Q/Q- Oper. Margin- RSI (14)60.82 Volatility10.77% 11.52%
OptionableYes Debt/Eq0.00 EPS Q/Q-12.10% Profit Margin- Rel Volume1.03 Prev Close5.63
ShortableYes LT Debt/Eq0.00 EarningsMar 09 Payout- Avg Volume801.62K Price5.50
Recom1.90 SMA2012.89% SMA5029.50% SMA200-10.85% Volume507,641 Change-2.33%
Dec-31-19Resumed ROTH Capital Buy $12
Oct-21-19Initiated Needham Buy $18
Apr-22-19Resumed Canaccord Genuity Buy
Feb-01-18Resumed H.C. Wainwright Buy $23
Jan-29-18Initiated Ladenburg Thalmann Buy $25.50
Jan-26-18Initiated Seaport Global Securities Buy $16
Oct-02-17Upgrade Cantor Fitzgerald Neutral → Overweight $4 → $17
Sep-29-17Upgrade Piper Jaffray Neutral → Overweight
Aug-15-17Upgrade ROTH Capital Neutral → Buy
Aug-15-17Downgrade Oppenheimer Outperform → Perform
Aug-15-17Downgrade Jefferies Buy → Hold
Aug-08-17Downgrade ROTH Capital Buy → Neutral
Aug-08-17Downgrade H.C. Wainwright Buy → Neutral $7
Aug-07-17Downgrade Piper Jaffray Overweight → Neutral
Aug-07-17Downgrade Maxim Group Buy → Hold
Aug-07-17Downgrade Cantor Fitzgerald Overweight → Neutral $28 → $4
Mar-28-17Reiterated H.C. Wainwright Buy $22 → $30
Feb-24-17Initiated Maxim Group Buy $32
Dec-22-16Initiated Cantor Fitzgerald Overweight $28
Dec-06-16Resumed Jefferies Buy
May-27-20 06:45AM  
Zynerba Pharmaceuticals Announces Positive Top Line Results from Exploratory Open Label Phase 2 BRIGHT Trial of Zygel in Autism Spectrum Disorder
GlobeNewswire -9.69%
May-26-20 06:52AM  
Zynerba Pharmaceuticals Announces New Two-Year Data from Open Label Extension of the Phase 2 FAB-C Trial in Patients with Fragile X at 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session
GlobeNewswire
06:50AM  
Zynerba Pharmaceuticals Announces Presentation of Phase 2 BELIEVE Safety, Efficacy and Quality of Life Data in Developmental and Epileptic Encephalopathies (DEE) at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Session
GlobeNewswire
May-25-20 11:30AM  
Is Zynerba Pharmaceuticals (ZYNE) Stock Outpacing Its Medical Peers This Year?
Zacks
May-22-20 07:30AM  
Zynerba Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
GlobeNewswire +18.14%
May-21-20 08:00AM  
Zynerba Pharmaceuticals Changes Annual Meeting of Shareholders to Virtual-Only Format in Response to COVID-19 Pandemic
GlobeNewswire
May-11-20 06:50AM  
Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Highlights
GlobeNewswire +11.53%
Apr-28-20 01:01PM  
How Much is Zynerba Pharmaceuticals, Inc.'s (NASDAQ:ZYNE) CEO Getting Paid?
Simply Wall St.
Apr-10-20 08:00AM  
Zynerba Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
GlobeNewswire
Apr-02-20 05:45PM  
Zynerba Pharmaceuticals (ZYNE) Gains But Lags Market: What You Should Know
Zacks
Mar-25-20 05:50PM  
Zynerba Pharmaceuticals (ZYNE) Gains But Lags Market: What You Should Know
Zacks
Mar-10-20 06:50AM  
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights
GlobeNewswire +10.40%
Mar-09-20 08:30AM  
Zynerba Pharmaceuticals Announces Poster Presentations at the American Academy of Neurology (AAN) 2020 Annual Meeting
GlobeNewswire -13.93%
Mar-05-20 08:30AM  
Zynerba Pharmaceuticals to Present at the 32nd Annual ROTH Conference
GlobeNewswire
Mar-03-20 12:08PM  
Zynerba Pharmaceuticals Presents Data Showing that the Baseline Characteristics of Patients in Phase 2 BRIGHT Trial in Autism Spectrum Disorder Indicate a Moderate-to-Severe Study Population
GlobeNewswire
12:07PM  
Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers
GlobeNewswire
Mar-02-20 05:45PM  
Zynerba Pharmaceuticals (ZYNE) Stock Sinks As Market Gains: What You Should Know
Zacks
Feb-26-20 08:49AM  
What's in the Cards for Zynerba (ZYNE) This Earnings Season?
Zacks -8.47%
06:50AM  
Zynerba Pharmaceuticals Announces the Completion of Enrollment in the Pivotal CONNECT-FX Trial of Zygel in Fragile X Syndrome
GlobeNewswire
Feb-25-20 11:21AM  
Zynerba Pharmaceuticals, Inc.'s (NASDAQ:ZYNE) Path To Profitability
Simply Wall St. +7.13%
07:15AM  
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with Purified Cannabidiol
GlobeNewswire
Feb-20-20 08:30AM  
Zynerba Pharmaceuticals Announces Presentations at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Annual Meeting
GlobeNewswire
Feb-18-20 09:07AM  
Zynerba Pharmaceuticals Enters Oversold Territory
Zacks +8.46%
Feb-10-20 05:45PM  
Zynerba Pharmaceuticals (ZYNE) Gains But Lags Market: What You Should Know
Zacks
08:05AM  
3 Strong Buy Healthcare Stocks With Triple-Digit Upside
TipRanks
Feb-03-20 05:45PM  
Zynerba Pharmaceuticals (ZYNE) Stock Sinks As Market Gains: What You Should Know
Zacks
06:45AM  
Zynerba Pharmaceuticals Announces Achievement of Patient Screening Target for Pivotal Trial of Zygel in Fragile X Syndrome
GlobeNewswire
Jan-31-20 03:45PM  
Top Marijuana Stocks on the NASDAQ
Investopedia
Jan-28-20 05:45PM  
Zynerba Pharmaceuticals (ZYNE) Stock Sinks As Market Gains: What You Should Know
Zacks
Jan-14-20 05:50PM  
Zynerba Pharmaceuticals (ZYNE) Dips More Than Broader Markets: What You Should Know
Zacks
Jan-13-20 09:15AM  
A Hectic but Positive First Full Week of 2020
Zacks
06:50AM  
Zynerba Pharmaceuticals Announces that Enrollment is Nearing Completion in Pivotal CONNECT-FX Trial in Fragile X Syndrome
GlobeNewswire
06:45AM  
Zynerba Pharmaceuticals Announces Achievement of Enrollment Target in Phase 2 Trial of Zygel in Autism Spectrum Disorder
GlobeNewswire
Jan-08-20 10:38AM  
Easy Come, Easy Go: How Zynerba Pharmaceuticals (NASDAQ:ZYNE) Shareholders Got Unlucky And Saw 71% Of Their Cash Evaporate
Simply Wall St.
Dec-23-19 12:10PM  
FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm
ACCESSWIRE
10:12AM  
FINAL DEADLINE ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Deadline: December 23, 2019
ACCESSWIRE
10:00AM  
ZYNE FINAL DEADLINE: ROSEN LAW FIRM Reminds Zynerba Pharmaceuticals, Inc. Investors of Important Deadline Today in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm ZYNE
GlobeNewswire
09:36AM  
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Business Wire
09:34AM  
Ride the Cannabis Wave With These 3 Stocks
Zacks
Dec-22-19 09:23PM  
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
05:08PM  
Do Hedge Funds Love Zynerba Pharmaceuticals Inc (ZYNE)?
Insider Monkey
02:21PM  
The Week In Cannabis: Federal Spending Bill, Vaping Bans And More Corporate Carnage
Benzinga
Dec-20-19 05:20PM  
FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
04:01PM  
MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Business Wire
11:35AM  
The Zacks Analyst Blog Highlights: Uber, AES, CIRCOR International, Edwards Lifesciences and Zynerba Pharmaceuticals
Zacks
10:00AM  
UPCOMING DEADLINE ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Deadline: December 23, 2019
GlobeNewswire
Dec-19-19 02:01PM  
Uber Is Formally into the Staffing Business
Zacks +6.83%
01:32PM  
Zynerba Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
08:06AM  
New Strong Buy Stocks for December 19th
Zacks
Dec-18-19 04:16PM  
Pawar Law Group Reminds Investors of December 23 Deadline in Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE
GlobeNewswire -6.24%
12:57PM  
Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
12:28PM  
Pot Stock Short-Sellers Net Almost $1 Billion in 2019
Bloomberg
Dec-17-19 02:07PM  
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE
GlobeNewswire
01:43PM  
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
Dec-16-19 05:12PM  
Zynerba Analyst Says Stock A Buy Ahead Of Zygel Data Release In 2020
Benzinga +13.49%
11:19AM  
Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
10:39AM  
UPCOMING DEADLINE ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Deadline: December 23, 2019
ACCESSWIRE
07:05AM  
New Strong Buy Stocks for December 16th
Zacks
Dec-13-19 10:00AM  
iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions
GlobeNewswire
Dec-12-19 10:23AM  
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
Dec-11-19 08:19PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE
GlobeNewswire
04:31PM  
ZYNE DEADLINE: Zhang Investor Law Reminds Investors of December 23 Deadline in Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE
GlobeNewswire
04:30PM  
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infosys, Zynerba, iRobot, and Zendesk and Encourages Investors to Contact the Firm
PR Newswire
Dec-09-19 10:08AM  
iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)- Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Actions
ACCESSWIRE
Dec-06-19 05:23PM  
ZYNE NOTICE: Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE
GlobeNewswire
11:30AM  
Is Zynerba Pharmaceuticals (ZYNE) Stock Outpacing Its Medical Peers This Year?
Zacks
10:00AM  
iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions
GlobeNewswire
09:22AM  
Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
Dec-05-19 11:32AM  
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile -5.36%
Dec-04-19 04:00PM  
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ADTRAN, Domo, Infosys, and Zynerba and Encourages Investors to Contact the Firm
GlobeNewswire
04:00PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE
ACCESSWIRE
03:51PM  
INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Aurora Cannabis, Inc., and Zynerba Pharmaceuticals of Filing Deadlines
GlobeNewswire
Dec-02-19 05:52PM  
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE
GlobeNewswire
10:15AM  
iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions
ACCESSWIRE
Nov-29-19 10:00AM  
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action - iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
GlobeNewswire
Nov-27-19 03:00PM  
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zynerba, iRobot, Zendesk, and PG&E Corporation and Encourages Investors to Contact the Firm
GlobeNewswire
01:17PM  
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE
GlobeNewswire
Nov-26-19 08:36AM  
Generic Drugmakers Gain as Price-Fixing Probe Nears an End
Zacks
Nov-25-19 03:35PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE
ACCESSWIRE
10:34AM  
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action - iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
ACCESSWIRE
Nov-23-19 08:10AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE
ACCESSWIRE
Nov-22-19 11:55PM  
Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile -6.24%
03:00PM  
Bronstein, Gewirtz & Grossman, LLC Alerts Investors of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
GlobeNewswire
10:35AM  
Bronstein, Gewirtz & Grossman, LLC Alerts of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
ACCESSWIRE
Nov-21-19 09:47AM  
ZYNE ALERT: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE
GlobeNewswire
05:00AM  
Zynerba- CBD and Transdermal Delivery
MoneyShow
Nov-20-19 05:29PM  
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Domo, Infosys, Zynerba, and iRobot and Encourages Investors to Contact the Firm
GlobeNewswire
03:10PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE
GlobeNewswire
10:33AM  
Bronstein, Gewirtz & Grossman, LLC Alerts Investors of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
ACCESSWIRE
Nov-19-19 10:58AM  
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
Nov-18-19 08:18PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE
CNW Group
10:32AM  
Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
ACCESSWIRE
Nov-16-19 08:43AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE
ACCESSWIRE
Nov-15-19 03:00PM  
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
GlobeNewswire
10:48AM  
Zynerba Pharmaceuticals Enters Oversold Territory
Zacks
10:04AM  
Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)
ACCESSWIRE
09:57AM  
Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
Nov-13-19 06:45PM  
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zynerba, iRobot, Zendesk, and PG&E Corporation and Encourages Investors to Contact the Firm
GlobeNewswire
04:40PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ZYNE
ACCESSWIRE
03:37PM  
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm
Newsfile
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is developing Zygel, a transdermal cannabidiol gel, which is in Phase II clinical trial for treating children and adolescent patients with developmental and epileptic encephalopathies; is in Phase II/III clinical trial to treat children and adolescent patients with fragile X syndrome; and is in Phase II clinical trial for treating children and adolescent patients with autism spectrum disorder. It is also developing ZYN001, a pro-drug of tetrahydrocannabinol. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Devon, Pennsylvania.
open in yahoo | open in reuters | open in google